Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000167711
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
||
|
NDF-RT |
N0000175823
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
||
|
WHO-ATC |
A16AB05
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
||
|
WHO-VATC |
QA16AB05
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
ALDURAZYME (AUTHOURIZED: MUCOPOLYSACCHARIDOSIS I)
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/01/022
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
||
|
FDA ORPHAN DRUG |
106097
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
||
|
NCI_THESAURUS |
C29726
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
LL-41
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
SUB20048
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
100000089543
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
DB00090
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
m6205
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
WP58SVM6R4
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
4997
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
392509
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | RxNorm | ||
|
210589-09-6
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
Iduronidase
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
8015
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
Laronidase
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
WP58SVM6R4
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
C83864
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201595
Created by
admin on Fri Dec 15 15:34:20 GMT 2023 , Edited by admin on Fri Dec 15 15:34:20 GMT 2023
|
PRIMARY |
ACTIVE MOIETY